Project: Rationalized Tailored Targeted Therapy for Cancer: The Triple-T Service

Triple-T combines the expertise of 2 companies specialized in kinase activity and genomic profiling with academically developed technologies to provide doctors and patients with information on druggable and drug-resistance pathways of individual lung tumors. This first commercial service of its kind will enable clinicians to rationally choose kinase inhibitor(s) to treat (therapy resistant) patients better. Services will be later extended to other cancers.

Acronym	Triple-T2 (Reference Number: 9470)
Duration	01/04/2015 - 01/04/2018
Project Topic	Biological Sciences / Technologies
Network	Eurostars 2
Call	Eurostars Cut-Off 2

Project partner

Number	Name	Role	Country
20773	Pamgene International B.V.	Coordinator	Netherlands
20774	GenXPro GmbH	Partner	Germany
20775	University Medical Center Groningen	Partner	Netherlands